News

The following is a statement from the European Haemophilia Consortium (EHC) commenting on the European Medicines Agency (EMA) statement regards Covid-19 AstraZeneca vaccine: 19 March 2021 The European Haemophilia Consortium

Below is the European Medicines Agency (EMA) statement regards the Covid-19 Vaccine AstraZeneca: COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low

National Procurement process for Extended Half Life Factor IX concentrate has just been completed by the Haemophilia Product Selection and Monitoring Advisory Board (HPSMAB). The Society are represented on this

Our Conference & AGM 2021 took place virtually this year, with sessions taking place over the evenings of March 1 – 4. We are very pleased with how the conference

We’ve been uploading recordings from our ongoing series of webinars so you catch up on the ones you’ve missed at your convenience. The latest of which is \’Staying Healthy at

Continuing with our series of Webinars, we have further meetings coming up in February on; Wednesday, February 17, 2021 @ 6pm: Staying Healthy at Home: Physiotherapy and Exercise Groups with

Our AGM & Conference 2021 will take place virtually this year, over the evenings of March 1 – 4. AGM packs have gone out to members via An Post and

We are gauging the level of interest in participating in a Society Book Club. If you are interested, please e mail julia@haemophilia.ie by Friday, January 29. If there is sufficient

We have no current information on when and where people with haemophilia and other inherited bleeding disorders will be offered one of the licenced Covid-19 vaccines. Some work has been